NOTCH1
Ayala, ArcherDx Partner to Advance CDx for Notch Inhibitors
The partners are working together to advance tests that will identify which cancer patients have Notch activating mutations and fusions.
The partners are working together to advance tests that will identify which cancer patients have Notch activating mutations and fusions.